...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Combo with Enzalutamide in Phase 2 Metastatic Prostate Cancer Clinical Trial and with Pfizer’s PARPi, talazoparib, in Phase 1b/2 Triple Negative Breast Cancer Trial

Free
AGORACOM NEWS FLASH

BREAKING: betterU closes deal with USA Paramount Staffing for their newly launched Ready-To-Go SaaS Enterprise skills development

  • Entered into an annual SaaS agreement with one of the largest staffing firms in the USA, Paramount Staffing
  • Paramount, is a $200+ Million USD Staffing Firm with over 300 employees across the USA and Canada
  • betterU has been able to curate and integrate a Ready-To-Go content library across top subjects so that HR managers could provide simple access to their entire organization

Betteru large

Hub On AGORACOM / Read Release / Watch Recent Interview

Off topic Forum: Zenith Epigenetics